Researchers have determined that healthcare providers increased their ability to make Alzheimer's disease (AD) probability judgments on their patients when they used the PrecivityAD2tm blood biomarker ...
Researchers have determined that healthcare providers increased their ability to make Alzheimer’s disease (AD) probability judgments on their patients when they used the PrecivityAD2™ blood biomarker ...
With expertise in research, fundraising, policy and more, our staff are dedicated to making breakthroughs possible. Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined ...